Global Artesunate Tablet Market Outlook 2022

SKU ID :QYR-19854630 | Published Date: 05-Jan-2022 | No. of pages: 104
Artesunate (AS) is a medication used to treat malaria. The intravenous form is preferred to quinidine for severe malaria. Often it is used as part of combination therapy. It is not used for the prevention of malaria.
Global Artesunate Tablet main players include Fosun Pharma (Guilin), Ipca Laboratories, Sanofi Aventis, Ajanta Pharma, Shin Poong, Cipla, Acino, MCW Healthcare, etc., totally accounting for about 70%. Central and South America is the largest market, with a share over 75%. As for the types of products, it can be divided into PA 90 Content, PA 95 Content and PA 98 Content. The most common product is Monoaromatic Artesunate and Compound Artesunate. In terms of applications, it is widely used in Hospital, Clinic and Others. The most application is in Hospital, with a share over 67%.

The global Artesunate Tablet market was valued at US$ 148 million in 2020 and is expected to reach US$ 225.5 million by the end of 2027, growing at a CAGR of 6.0% during 2021-2027.
This report focuses on Artesunate Tablet volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Artesunate Tablet market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global Artesunate Tablet Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
Monoaromatic Artesunate
Compound Artesunate

Segment by Application
Hospital
Clinic
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Fosun Pharma (Guilin)
Ipca Laboratories
Sanofi Aventis
Ajanta Pharma
Shin Poong
Cipla
Acino
MCW Healthcare
  • PRICE
  • $2900
    $5800
    $4350
    Buy Now

Our Clients